Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178

Molecular and Cellular Biology

Volumn 26, Issue 5, 2006, Pages 1948-1954

  Wang, Jian ^a   Fillebeen, Carine ^a   Chen, Guohua ^a   Andriopoulos, Bill ^a   Pantopoulos, Kostas ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; BETA ACTIN; CALCEIN; CYCLOHEXIMIDE; DACTINOMYCIN; DIMETHYLOXALYLGLYCINE; FERRIC AMMONIUM CITRATE; GLYCINE DERIVATIVE; IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; NITRITE; NITROPRUSSIDE SODIUM; OXYGENASE; PROTEASOME; S NITROSOGLUTATHIONE; SUCCINYLACETONE; TETRACYCLINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; HUMAN; HUMAN CELL; MACROPHAGE; NITROSYLATION; PHOTODEGRADATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; RNA BINDING; UBIQUITINATION; WESTERN BLOTTING;

CYSTEINE; FERRIC COMPOUNDS; HUMANS; IRON; IRON REGULATORY PROTEIN 2; KINETICS; NITRIC OXIDE DONORS; NITROPRUSSIDE; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; QUATERNARY AMMONIUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 33644526911     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.5.1948-1954.2006     Document Type: Article

References (41)

1. 2+ exchanger in C6 glioma cells. J. Neurochem. 74:1505-1513.
2. Bates, J. N., M. T. Baker, R. Guerra, Jr., and D. G. Harrison. 1991. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 42(Suppl.):S157-S165.
3. Bourdon, E., D. K. Kang, M. C. Ghosh, S. K. Drake, J. Wey, R. L. Levine, and T. A. Rouault. 2003. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2. Blood Cells Mol. Dis. 31:247-255.
4. Chung, K. K., B. Thomas, X. Li, O. Pletnikova, J. C. Troncoso, L. Marsh, V. L. Dawson, and T. M. Dawson. 2004. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304: 1328-1331.
5. Cooperman, S. S., E. G. Meyron-Holtz, H. Olivierre-Wilson, M. C. Ghosh, J. P. McConnell, and T. A. Rouault. 2005. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron regulatory protein 2. Blood 106:1084-1091.
6. Feelisch, M. 1998. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch. Pharmacol. 358:113-122.
7. Feger, F., H. Ferry-Dumazet, M. Mamani Matsuda, J. Bordenave, M. Dupouy, A. K. Nussler, M. Arock, L. Devevey, J. Nafziger, J. J. Guillosson, J. Reiffers, and M. D. Mossalayi. 2001. Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide. Cancer Res. 61:5289-5294.
8. Ferry-Dumazet, H., M. Mamani-Matsuda, M. Dupouy, F. Belloc, D. Thiolat, G. Marit, M. Arock, J. Reiffers, and M. D. Mossalayi. 2002. Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron. Leukemia 16:708-715.
9. Friederich, J. A., and J. F. t. Butterworth. 1995. Sodium nitroprusside: twenty years and counting. Anesth. Analg. 81:152-162.
10. Galy, B., D. Ferring, B. Minana, O. Bell, H. G. Janser, M. Muckenthaler, K. Schumann, and M. W. Hentze. 2005. Altered body iron distribution and microcytosis in mice deficient for iron regulatory protein 2 (IRP2). Blood 106:2580-2589.
11. Goessling, L. S., D. P. Mascotti, and R. E. Thach. 1998. Involvement of heme in the degradation of iron-regulatory protein 2. J. Biol. Chem. 273:12555-12557.
12. Hanson, E. S., M. L. Rawlins, and E. A. Leibold. 2003. Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278:40337-40342.
13. Hentze, M. W., M. U. Muckenthaler, and N. C. Andrews. 2004. Balancing acts; molecular control of mammalian iron metabolism. Cell 117:285-297.
14. Hess, D. T., A. Matsumoto, S. O. Kim, H. E. Marshall, and J. S. Stamler. 2005. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell. Biol. 6:150-166.
15. Ishikawa, H., M. Kato, H. Hori, K. Ishimori, T. Kirisako, F. Tokunaga, and K. Iwai. 2005. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol. Cell 19:171-181.
16. Iwai, K., S. K. Drake, N. B. Wehr, A. M. Weissman, T. LaVaute, N. Minato, R. D. Klausner, R. L. Levine, and T. A. Rouault. 1998. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc. Natl. Acad. Sci. USA 95:4924-4928.
17. Iwai, K., R. D. Klausner, and T. A. Rouault. 1995. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:5350-5357.
18. Jaakkola, P., D. R. Mole, Y. M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, A. Kriegsheim, H. F. Hebestreit, M. Mukherji, C. J. Schofield, P. H. Maxwell, C. W. Pugh, and P. J. Ratcliffe. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by Deregulated prolyl hydroxylation. Science 292:468-472.
19. Jeong, J., T. A. Rouault, and R. L. Levine. 2004. Identification of a heme-sensing domain in iron regulatory protein 2. J. Biol. Chem. 279:45450-45454.
20. Kakhlon, O., and Z. I. Cabantchik. 2002. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic. Biol. Med. 33:1037-1046.
21. Kang, D. K., J. Jeong, S. K. Drake, N. Wehr, T. A. Rouault, and R. L. Levine. 2003. Iron-regulatory protein 2 as iron sensor: iron-dependent oxidative modification of cysteine. J. Biol. Chem. 278:14857-14864.
22. Kim, S., and P. Ponka. 1999. Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2. J. Biol. Chem. 274:33035-33042.
23. Kim, S., and P. Ponka. 2000. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275:6220-6226.
24. Kim, S., and P. Ponka. 2002. Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis. Blood Cells Mol. Dis. 29:400-410.
25. Kim, S., and P. Ponka. 2002. Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis. Proc. Natl. Acad. Sci. USA 99:12214-12219.
26. Kim, S., S. S. Wing, and P. Ponka. 2004. S nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol. Cell. Biol. 24:330-337.
27. Konijn, A. M., H. Glickstein, B. Vaisman, E. G. Mejron-Holtz, I. N. Slotki, and Z. I. Cabantchik. 1999. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 94:2128-2134.
28. LaVaute, T., S. Smith, S. Cooperman, K. Iwai, W. Land, E. Meyron-Holtz, S. K. Drake, G. Miller, M. Abu-Asab, M. Tsokos, R. Switzer III, A. Grinberg, P. Love, N. Tresser, and T. A. Rouault. 2001. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:209-214.
29. Meyron-Holtz, E. G., M. C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, U. V. Berger, W. Land, H. Ollivierre-Wilson, A. Grinberg, P. Love, and T. A. Rouault. 2004. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 23:386-395.
30. Meyron-Holtz, E. G., M. C. Ghosh, and T. A. Rouault. 2004. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306:2087-2090.
31. Mueller, S., and K. Pantopoulos. 2002. Activation of iron regulatory protein-1 (IRP1) by oxidative stress. Methods Enzymol. 348:324-337.
32. Pantopoulos, K. 2004. Iron metabolism and the IRE/IRP regulatory system: an update. Ann. N. Y. Acad. Sci. 1012:1-13.
33. 2) control mammalian iron metabolism by different pathways. Mol. Cell. Biol. 16:3781-3788.
34. Rao, D. N., S. Elguindi, and P. J. O'Brien. 1991. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch. Biochem. Biophys. 286:30-37.
35. Rauhala, P., T. Andoh, K. Yeh, and C. C. Chiueh. 2002. Contradictory effects of sodium nitroprusside and S-nitroso-N-acetylpenicillamine on oxidative stress in brain dopamine neurons in vivo. Ann. N. Y. Acad. Sci. 962:60-72.
36. Rauhala, P., A. Khaldi, K. P. Mohanakumar, and C. C. Chiueh. 1998. Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside. Free Radic. Biol. Med. 24:1065-1073.
37. Roncaroli, F., R. van Eldik, and J. A. Olabe. 2005. Release of NO from reduced nitroprusside ion: iron-dinitrosyl formation and NO-disproportionation reactions. Inorg. Chem. 44:2781-2790.
38. Smith, S. R., S. Cooperman, T. Lavaute, N. Tresser, M. Ghosh, E. Meyron-Holtz, W. Land, H. Ollivierre, B. Jortner, R. Switzer III, A. Messing, and T. A. Rouault. 2004. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann. N. Y. Acad. Sci. 1012:65-83.
39. Wang, J., G. Chen, M. Muckenthaler, B. Galy, M. W. Hentze, and K. Pantopoulos. 2004. Iron-mediated degradation of IRP2: an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell. Biol. 24:954-965.
40. Wang, J., G. Chen, and K. Pantopoulos. 2005. Nitric oxide inhibits the degradation of IRP2. Mol. Cell. Biol. 25:1347-1353.
41. Yamanaka, K., H. Ishikawa, Y. Megumi, F. Tokunaga, M. Kanie, T. A. Rouault, I. Morishima, N. Minato, K. Ishimori, and K. Iwai. 2003. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5:336-340.